Global Human Vaccines Market Growth 2020-2025
The report requires updating with new data and is sent in 48 hours after order is placed.
According to this study, over the next five years the Human Vaccines market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Human Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Vaccines market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Human Vaccines, covering the supply chain analysis, impact assessment to the Human Vaccines market size growth rate in several scenarios, and the measures to be undertaken by Human Vaccines companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Research objectives
According to this study, over the next five years the Human Vaccines market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Human Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Vaccines market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Human Vaccines, covering the supply chain analysis, impact assessment to the Human Vaccines market size growth rate in several scenarios, and the measures to be undertaken by Human Vaccines companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
- Varicella
- Influenza
- Polio
- Hepatitis A
- Rabies
- BCG
- Hepatitis B
- Other
- Adults
- Children
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CNBG
- SANOFI
- Changsheng Life
- ChengDa Bio
- Kangtai
- Zhifei
- Walvax Biotechnology
- SINOVAC BIOTECH
- GSK
- Hissen
- Adimmune
- Zhongyianke Biotech
- Rong An
- Tiantan biological
- Hualan Bio
- Changchun Baike
- NuoCheng Bio
Research objectives
- To study and analyze the global Human Vaccines consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of Human Vaccines market by identifying its various subsegments.
- Focuses on the key global Human Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Human Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Human Vaccines submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Vaccines Consumption 2015-2025
2.1.2 Human Vaccines Consumption CAGR by Region
2.2 Human Vaccines Segment by Type
2.2.1 Varicella
2.2.2 Influenza
2.2.3 Polio
2.2.4 Hepatitis A
2.2.5 Rabies
2.2.6 BCG
2.2.7 Hepatitis B
2.2.8 Other
2.3 Human Vaccines Consumption by Type
2.3.1 Global Human Vaccines Consumption Market Share by Type (2015-2020)
2.3.2 Global Human Vaccines Revenue and Market Share by Type (2015-2020)
2.3.3 Global Human Vaccines Sale Price by Type (2015-2020)
2.4 Human Vaccines Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Human Vaccines Consumption by Application
2.5.1 Global Human Vaccines Consumption Market Share by Type (2015-2020)
2.5.2 Global Human Vaccines Value and Market Share by Type (2015-2020)
2.5.3 Global Human Vaccines Sale Price by Type (2015-2020)
3 GLOBAL HUMAN VACCINES BY COMPANY
3.1 Global Human Vaccines Sales Market Share by Company
3.1.1 Global Human Vaccines Sales by Company (2018-2020)
3.1.2 Global Human Vaccines Sales Market Share by Company (2018-2020)
3.2 Global Human Vaccines Revenue Market Share by Company
3.2.1 Global Human Vaccines Revenue by Company (2018-2020)
3.2.2 Global Human Vaccines Revenue Market Share by Company (2018-2020)
3.3 Global Human Vaccines Sale Price by Company
3.4 Global Human Vaccines Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Human Vaccines Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Human Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 HUMAN VACCINES BY REGIONS
4.1 Human Vaccines by Regions
4.2 Americas Human Vaccines Consumption Growth
4.3 APAC Human Vaccines Consumption Growth
4.4 Europe Human Vaccines Consumption Growth
4.5 Middle East & Africa Human Vaccines Consumption Growth
5 AMERICAS
5.1 Americas Human Vaccines Consumption by Countries
5.1.1 Americas Human Vaccines Consumption by Countries (2015-2020)
5.1.2 Americas Human Vaccines Value by Countries (2015-2020)
5.2 Americas Human Vaccines Consumption by Type
5.3 Americas Human Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Human Vaccines Consumption by Regions
6.1.1 APAC Human Vaccines Consumption by Regions (2015-2020)
6.1.2 APAC Human Vaccines Value by Regions (2015-2020)
6.2 APAC Human Vaccines Consumption by Type
6.3 APAC Human Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 EUROPE
7.1 Europe Human Vaccines by Countries
7.1.1 Europe Human Vaccines Consumption by Countries (2015-2020)
7.1.2 Europe Human Vaccines Value by Countries (2015-2020)
7.2 Europe Human Vaccines Consumption by Type
7.3 Europe Human Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Vaccines by Countries
8.1.1 Middle East & Africa Human Vaccines Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Human Vaccines Value by Countries (2015-2020)
8.2 Middle East & Africa Human Vaccines Consumption by Type
8.3 Middle East & Africa Human Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Human Vaccines Distributors
10.3 Human Vaccines Customer
11 GLOBAL HUMAN VACCINES MARKET FORECAST
11.1 Global Human Vaccines Consumption Forecast (2021-2025)
11.2 Global Human Vaccines Forecast by Regions
11.2.1 Global Human Vaccines Forecast by Regions (2021-2025)
11.2.2 Global Human Vaccines Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Human Vaccines Forecast by Type
11.8 Global Human Vaccines Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 CNBG
12.1.1 Company Information
12.1.2 Human Vaccines Product Offered
12.1.3 CNBG Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 CNBG Latest Developments
12.2 SANOFI
12.2.1 Company Information
12.2.2 Human Vaccines Product Offered
12.2.3 SANOFI Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 SANOFI Latest Developments
12.3 Changsheng Life
12.3.1 Company Information
12.3.2 Human Vaccines Product Offered
12.3.3 Changsheng Life Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Changsheng Life Latest Developments
12.4 ChengDa Bio
12.4.1 Company Information
12.4.2 Human Vaccines Product Offered
12.4.3 ChengDa Bio Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 ChengDa Bio Latest Developments
12.5 Kangtai
12.5.1 Company Information
12.5.2 Human Vaccines Product Offered
12.5.3 Kangtai Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Kangtai Latest Developments
12.6 Zhifei
12.6.1 Company Information
12.6.2 Human Vaccines Product Offered
12.6.3 Zhifei Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Zhifei Latest Developments
12.7 Walvax Biotechnology
12.7.1 Company Information
12.7.2 Human Vaccines Product Offered
12.7.3 Walvax Biotechnology Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Walvax Biotechnology Latest Developments
12.8 SINOVAC BIOTECH
12.8.1 Company Information
12.8.2 Human Vaccines Product Offered
12.8.3 SINOVAC BIOTECH Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 SINOVAC BIOTECH Latest Developments
12.9 GSK
12.9.1 Company Information
12.9.2 Human Vaccines Product Offered
12.9.3 GSK Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 GSK Latest Developments
12.10 Hissen
12.10.1 Company Information
12.10.2 Human Vaccines Product Offered
12.10.3 Hissen Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Hissen Latest Developments
12.11 Adimmune
12.11.1 Company Information
12.11.2 Human Vaccines Product Offered
12.11.3 Adimmune Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Adimmune Latest Developments
12.12 Zhongyianke Biotech
12.12.1 Company Information
12.12.2 Human Vaccines Product Offered
12.12.3 Zhongyianke Biotech Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Zhongyianke Biotech Latest Developments
12.13 Rong An
12.13.1 Company Information
12.13.2 Human Vaccines Product Offered
12.13.3 Rong An Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Rong An Latest Developments
12.14 Tiantan biological
12.14.1 Company Information
12.14.2 Human Vaccines Product Offered
12.14.3 Tiantan biological Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Tiantan biological Latest Developments
12.15 Hualan Bio
12.15.1 Company Information
12.15.2 Human Vaccines Product Offered
12.15.3 Hualan Bio Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Hualan Bio Latest Developments
12.16 Changchun Baike
12.16.1 Company Information
12.16.2 Human Vaccines Product Offered
12.16.3 Changchun Baike Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Changchun Baike Latest Developments
12.17 NuoCheng Bio
12.17.1 Company Information
12.17.2 Human Vaccines Product Offered
12.17.3 NuoCheng Bio Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 NuoCheng Bio Latest Developments
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Vaccines Consumption 2015-2025
2.1.2 Human Vaccines Consumption CAGR by Region
2.2 Human Vaccines Segment by Type
2.2.1 Varicella
2.2.2 Influenza
2.2.3 Polio
2.2.4 Hepatitis A
2.2.5 Rabies
2.2.6 BCG
2.2.7 Hepatitis B
2.2.8 Other
2.3 Human Vaccines Consumption by Type
2.3.1 Global Human Vaccines Consumption Market Share by Type (2015-2020)
2.3.2 Global Human Vaccines Revenue and Market Share by Type (2015-2020)
2.3.3 Global Human Vaccines Sale Price by Type (2015-2020)
2.4 Human Vaccines Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Human Vaccines Consumption by Application
2.5.1 Global Human Vaccines Consumption Market Share by Type (2015-2020)
2.5.2 Global Human Vaccines Value and Market Share by Type (2015-2020)
2.5.3 Global Human Vaccines Sale Price by Type (2015-2020)
3 GLOBAL HUMAN VACCINES BY COMPANY
3.1 Global Human Vaccines Sales Market Share by Company
3.1.1 Global Human Vaccines Sales by Company (2018-2020)
3.1.2 Global Human Vaccines Sales Market Share by Company (2018-2020)
3.2 Global Human Vaccines Revenue Market Share by Company
3.2.1 Global Human Vaccines Revenue by Company (2018-2020)
3.2.2 Global Human Vaccines Revenue Market Share by Company (2018-2020)
3.3 Global Human Vaccines Sale Price by Company
3.4 Global Human Vaccines Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Human Vaccines Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Human Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 HUMAN VACCINES BY REGIONS
4.1 Human Vaccines by Regions
4.2 Americas Human Vaccines Consumption Growth
4.3 APAC Human Vaccines Consumption Growth
4.4 Europe Human Vaccines Consumption Growth
4.5 Middle East & Africa Human Vaccines Consumption Growth
5 AMERICAS
5.1 Americas Human Vaccines Consumption by Countries
5.1.1 Americas Human Vaccines Consumption by Countries (2015-2020)
5.1.2 Americas Human Vaccines Value by Countries (2015-2020)
5.2 Americas Human Vaccines Consumption by Type
5.3 Americas Human Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Human Vaccines Consumption by Regions
6.1.1 APAC Human Vaccines Consumption by Regions (2015-2020)
6.1.2 APAC Human Vaccines Value by Regions (2015-2020)
6.2 APAC Human Vaccines Consumption by Type
6.3 APAC Human Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 EUROPE
7.1 Europe Human Vaccines by Countries
7.1.1 Europe Human Vaccines Consumption by Countries (2015-2020)
7.1.2 Europe Human Vaccines Value by Countries (2015-2020)
7.2 Europe Human Vaccines Consumption by Type
7.3 Europe Human Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Vaccines by Countries
8.1.1 Middle East & Africa Human Vaccines Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Human Vaccines Value by Countries (2015-2020)
8.2 Middle East & Africa Human Vaccines Consumption by Type
8.3 Middle East & Africa Human Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Human Vaccines Distributors
10.3 Human Vaccines Customer
11 GLOBAL HUMAN VACCINES MARKET FORECAST
11.1 Global Human Vaccines Consumption Forecast (2021-2025)
11.2 Global Human Vaccines Forecast by Regions
11.2.1 Global Human Vaccines Forecast by Regions (2021-2025)
11.2.2 Global Human Vaccines Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Human Vaccines Forecast by Type
11.8 Global Human Vaccines Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 CNBG
12.1.1 Company Information
12.1.2 Human Vaccines Product Offered
12.1.3 CNBG Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 CNBG Latest Developments
12.2 SANOFI
12.2.1 Company Information
12.2.2 Human Vaccines Product Offered
12.2.3 SANOFI Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 SANOFI Latest Developments
12.3 Changsheng Life
12.3.1 Company Information
12.3.2 Human Vaccines Product Offered
12.3.3 Changsheng Life Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Changsheng Life Latest Developments
12.4 ChengDa Bio
12.4.1 Company Information
12.4.2 Human Vaccines Product Offered
12.4.3 ChengDa Bio Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 ChengDa Bio Latest Developments
12.5 Kangtai
12.5.1 Company Information
12.5.2 Human Vaccines Product Offered
12.5.3 Kangtai Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Kangtai Latest Developments
12.6 Zhifei
12.6.1 Company Information
12.6.2 Human Vaccines Product Offered
12.6.3 Zhifei Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Zhifei Latest Developments
12.7 Walvax Biotechnology
12.7.1 Company Information
12.7.2 Human Vaccines Product Offered
12.7.3 Walvax Biotechnology Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Walvax Biotechnology Latest Developments
12.8 SINOVAC BIOTECH
12.8.1 Company Information
12.8.2 Human Vaccines Product Offered
12.8.3 SINOVAC BIOTECH Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 SINOVAC BIOTECH Latest Developments
12.9 GSK
12.9.1 Company Information
12.9.2 Human Vaccines Product Offered
12.9.3 GSK Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 GSK Latest Developments
12.10 Hissen
12.10.1 Company Information
12.10.2 Human Vaccines Product Offered
12.10.3 Hissen Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Hissen Latest Developments
12.11 Adimmune
12.11.1 Company Information
12.11.2 Human Vaccines Product Offered
12.11.3 Adimmune Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Adimmune Latest Developments
12.12 Zhongyianke Biotech
12.12.1 Company Information
12.12.2 Human Vaccines Product Offered
12.12.3 Zhongyianke Biotech Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Zhongyianke Biotech Latest Developments
12.13 Rong An
12.13.1 Company Information
12.13.2 Human Vaccines Product Offered
12.13.3 Rong An Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Rong An Latest Developments
12.14 Tiantan biological
12.14.1 Company Information
12.14.2 Human Vaccines Product Offered
12.14.3 Tiantan biological Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Tiantan biological Latest Developments
12.15 Hualan Bio
12.15.1 Company Information
12.15.2 Human Vaccines Product Offered
12.15.3 Hualan Bio Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Hualan Bio Latest Developments
12.16 Changchun Baike
12.16.1 Company Information
12.16.2 Human Vaccines Product Offered
12.16.3 Changchun Baike Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Changchun Baike Latest Developments
12.17 NuoCheng Bio
12.17.1 Company Information
12.17.2 Human Vaccines Product Offered
12.17.3 NuoCheng Bio Human Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 NuoCheng Bio Latest Developments
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Research Methodology
Table 2. Data Source
Table 3. Human Vaccines Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Varicella
Table 5. Major Players of Influenza
Table 6. Major Players of Polio
Table 7. Major Players of Hepatitis A
Table 8. Major Players of Rabies
Table 9. Major Players of BCG
Table 10. Major Players of Hepatitis B
Table 11. Major Players of Other
Table 12. Global Consumption Sales by Type (2015-2020)
Table 13. Global Human Vaccines Consumption Market Share by Type (2015-2020)
Table 14. Global Human Vaccines Revenue by Type (2015-2020) ($ million)
Table 15. Global Human Vaccines Value Market Share by Type (2015-2020) ($ Millions)
Table 16. Global Human Vaccines Sale Price by Type (2015-2020)
Table 17. Global Consumption Sales by Application (2015-2020)
Table 18. Global Human Vaccines Consumption Market Share by Application (2015-2020)
Table 19. Global Human Vaccines Value by Application (2015-2020)
Table 20. Global Human Vaccines Value Market Share by Application (2015-2020)
Table 21. Global Human Vaccines Sale Price by Application (2015-2020)
Table 22. Global Human Vaccines Sales by Company (2017-2019) (K Units)
Table 23. Global Human Vaccines Sales Market Share by Company (2017-2019)
Table 24. Global Human Vaccines Revenue by Company (2017-2019) ($ Millions)
Table 25. Global Human Vaccines Revenue Market Share by Company (2017-2019)
Table 26. Global Human Vaccines Sale Price by Company (2017-2019)
Table 27. Global Human Vaccines Manufacturing Base Distribution and Sales Area by Manufacturers
Table 28. Players Human Vaccines Products Offered
Table 29. Human Vaccines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 30. Global Human Vaccines Consumption by Regions 2015-2020 (K Units)
Table 31. Global Human Vaccines Consumption Market Share by Regions 2015-2020
Table 32. Global Human Vaccines Value by Regions 2015-2020 ($ Millions)
Table 33. Global Human Vaccines Value Market Share by Regions 2015-2020
Table 34. Americas Human Vaccines Consumption by Countries (2015-2020) (K Units)
Table 35. Americas Human Vaccines Consumption Market Share by Countries (2015-2020)
Table 36. Americas Human Vaccines Value by Countries (2015-2020) ($ Millions)
Table 37. Americas Human Vaccines Value Market Share by Countries (2015-2020)
Table 38. Americas Human Vaccines Consumption by Type (2015-2020) (K Units)
Table 39. Americas Human Vaccines Consumption Market Share by Type (2015-2020)
Table 40. Americas Human Vaccines Consumption by Application (2015-2020) (K Units)
Table 41. Americas Human Vaccines Consumption Market Share by Application (2015-2020)
Table 42. APAC Human Vaccines Consumption by Regions (2015-2020) (K Units)
Table 43. APAC Human Vaccines Consumption Market Share by Regions (2015-2020)
Table 44. APAC Human Vaccines Value by Regions (2015-2020) ($ Millions)
Table 45. APAC Human Vaccines Value Market Share by Regions (2015-2020)
Table 46. APAC Human Vaccines Consumption by Type (2015-2020) (K Units)
Table 47. APAC Human Vaccines Consumption Market Share by Type (2015-2020)
Table 48. APAC Human Vaccines Consumption by Application (2015-2020) (K Units)
Table 49. APAC Human Vaccines Consumption Market Share by Application (2015-2020)
Table 50. Europe Human Vaccines Consumption by Countries (2015-2020) (K Units)
Table 51. Europe Human Vaccines Consumption Market Share by Countries (2015-2020)
Table 52. Europe Human Vaccines Value by Countries (2015-2020) ($ Millions)
Table 53. Europe Human Vaccines Value Market Share by Countries (2015-2020)
Table 54. Europe Human Vaccines Consumption by Type (2015-2020) (K Units)
Table 55. Europe Human Vaccines Consumption Market Share by Type (2015-2020)
Table 56. Europe Human Vaccines Consumption by Application (2015-2020) (K Units)
Table 57. Europe Human Vaccines Consumption Market Share by Application (2015-2020)
Table 58. Middle East & Africa Human Vaccines Consumption by Countries (2015-2020) (K Units)
Table 59. Middle East & Africa Human Vaccines Consumption Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Human Vaccines Value by Countries (2015-2020) ($ Millions)
Table 61. Middle East & Africa Human Vaccines Value Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Human Vaccines Consumption by Type (2015-2020) (K Units)
Table 63. Middle East & Africa Human Vaccines Consumption Market Share by Type (2015-2020)
Table 64. Middle East & Africa Human Vaccines Consumption by Application (2015-2020) (K Units)
Table 65. Middle East & Africa Human Vaccines Consumption Market Share by Application (2015-2020)
Table 66. Human Vaccines Distributors List
Table 67. Human Vaccines Customer List
Table 68. Global Human Vaccines Consumption Forecast by Countries (2021-2025) (K Units)
Table 69. Global Human Vaccines Consumption Market Forecast by Regions
Table 70. Global Human Vaccines Value Forecast by Countries (2021-2025) ($ Millions)
Table 71. Global Human Vaccines Value Market Share Forecast by Regions
Table 72. Global Human Vaccines Consumption Forecast by Type (2021-2025) (K Units)
Table 73. Global Human Vaccines Consumption Market Share Forecast by Type (2021-2025)
Table 74. Global Human Vaccines Value Forecast by Type (2021-2025) ($ Millions)
Table 75. Global Human Vaccines Value Market Share Forecast by Type (2021-2025)
Table 76. Global Human Vaccines Consumption Forecast by Application (2021-2025) (K Units)
Table 77. Global Human Vaccines Consumption Market Share Forecast by Application (2021-2025)
Table 78. Global Human Vaccines Value Forecast by Application (2021-2025) ($ Millions)
Table 79. Global Human Vaccines Value Market Share Forecast by Application (2021-2025)
Table 80. CNBG Product Offered
Table 81. CNBG Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. CNBG Main Business
Table 83. CNBG Latest Developments
Table 84. CNBG Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. SANOFI Product Offered
Table 86. SANOFI Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. SANOFI Main Business
Table 88. SANOFI Latest Developments
Table 89. SANOFI Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. Changsheng Life Product Offered
Table 91. Changsheng Life Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. Changsheng Life Main Business
Table 93. Changsheng Life Latest Developments
Table 94. Changsheng Life Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. ChengDa Bio Product Offered
Table 96. ChengDa Bio Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. ChengDa Bio Main Business
Table 98. ChengDa Bio Latest Developments
Table 99. ChengDa Bio Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Kangtai Product Offered
Table 101. Kangtai Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. Kangtai Main Business
Table 103. Kangtai Latest Developments
Table 104. Kangtai Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Zhifei Product Offered
Table 106. Zhifei Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 107. Zhifei Main Business
Table 108. Zhifei Latest Developments
Table 109. Zhifei Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. Walvax Biotechnology Product Offered
Table 111. Walvax Biotechnology Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 112. Walvax Biotechnology Main Business
Table 113. Walvax Biotechnology Latest Developments
Table 114. Walvax Biotechnology Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 115. SINOVAC BIOTECH Product Offered
Table 116. SINOVAC BIOTECH Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. SINOVAC BIOTECH Main Business
Table 118. SINOVAC BIOTECH Latest Developments
Table 119. SINOVAC BIOTECH Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 120. GSK Product Offered
Table 121. GSK Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. GSK Main Business
Table 123. GSK Latest Developments
Table 124. GSK Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 125. Hissen Product Offered
Table 126. Hissen Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 127. Hissen Main Business
Table 128. Hissen Latest Developments
Table 129. Hissen Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 130. Adimmune Product Offered
Table 131. Adimmune Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 132. Adimmune Main Business
Table 133. Adimmune Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Adimmune Latest Developments
Table 135. Zhongyianke Biotech Product Offered
Table 136. Zhongyianke Biotech Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 137. Zhongyianke Biotech Main Business
Table 138. Zhongyianke Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Zhongyianke Biotech Latest Developments
Table 140. Rong An Product Offered
Table 141. Rong An Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 142. Rong An Main Business
Table 143. Rong An Latest Developments
Table 144. Rong An Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 145. Tiantan biological Product Offered
Table 146. Tiantan biological Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 147. Tiantan biological Main Business
Table 148. Tiantan biological Latest Developments
Table 149. Tiantan biological Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 150. Hualan Bio Product Offered
Table 151. Hualan Bio Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 152. Hualan Bio Main Business
Table 153. Hualan Bio Latest Developments
Table 154. Hualan Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 155. Changchun Baike Product Offered
Table 156. Changchun Baike Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 157. Changchun Baike Main Business
Table 158. Changchun Baike Latest Developments
Table 159. Changchun Baike Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 160. NuoCheng Bio Product Offered
Table 161. NuoCheng Bio Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 162. NuoCheng Bio Main Business
Table 163. NuoCheng Bio Latest Developments
Table 164. NuoCheng Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 1. Research Methodology
Table 2. Data Source
Table 3. Human Vaccines Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Varicella
Table 5. Major Players of Influenza
Table 6. Major Players of Polio
Table 7. Major Players of Hepatitis A
Table 8. Major Players of Rabies
Table 9. Major Players of BCG
Table 10. Major Players of Hepatitis B
Table 11. Major Players of Other
Table 12. Global Consumption Sales by Type (2015-2020)
Table 13. Global Human Vaccines Consumption Market Share by Type (2015-2020)
Table 14. Global Human Vaccines Revenue by Type (2015-2020) ($ million)
Table 15. Global Human Vaccines Value Market Share by Type (2015-2020) ($ Millions)
Table 16. Global Human Vaccines Sale Price by Type (2015-2020)
Table 17. Global Consumption Sales by Application (2015-2020)
Table 18. Global Human Vaccines Consumption Market Share by Application (2015-2020)
Table 19. Global Human Vaccines Value by Application (2015-2020)
Table 20. Global Human Vaccines Value Market Share by Application (2015-2020)
Table 21. Global Human Vaccines Sale Price by Application (2015-2020)
Table 22. Global Human Vaccines Sales by Company (2017-2019) (K Units)
Table 23. Global Human Vaccines Sales Market Share by Company (2017-2019)
Table 24. Global Human Vaccines Revenue by Company (2017-2019) ($ Millions)
Table 25. Global Human Vaccines Revenue Market Share by Company (2017-2019)
Table 26. Global Human Vaccines Sale Price by Company (2017-2019)
Table 27. Global Human Vaccines Manufacturing Base Distribution and Sales Area by Manufacturers
Table 28. Players Human Vaccines Products Offered
Table 29. Human Vaccines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 30. Global Human Vaccines Consumption by Regions 2015-2020 (K Units)
Table 31. Global Human Vaccines Consumption Market Share by Regions 2015-2020
Table 32. Global Human Vaccines Value by Regions 2015-2020 ($ Millions)
Table 33. Global Human Vaccines Value Market Share by Regions 2015-2020
Table 34. Americas Human Vaccines Consumption by Countries (2015-2020) (K Units)
Table 35. Americas Human Vaccines Consumption Market Share by Countries (2015-2020)
Table 36. Americas Human Vaccines Value by Countries (2015-2020) ($ Millions)
Table 37. Americas Human Vaccines Value Market Share by Countries (2015-2020)
Table 38. Americas Human Vaccines Consumption by Type (2015-2020) (K Units)
Table 39. Americas Human Vaccines Consumption Market Share by Type (2015-2020)
Table 40. Americas Human Vaccines Consumption by Application (2015-2020) (K Units)
Table 41. Americas Human Vaccines Consumption Market Share by Application (2015-2020)
Table 42. APAC Human Vaccines Consumption by Regions (2015-2020) (K Units)
Table 43. APAC Human Vaccines Consumption Market Share by Regions (2015-2020)
Table 44. APAC Human Vaccines Value by Regions (2015-2020) ($ Millions)
Table 45. APAC Human Vaccines Value Market Share by Regions (2015-2020)
Table 46. APAC Human Vaccines Consumption by Type (2015-2020) (K Units)
Table 47. APAC Human Vaccines Consumption Market Share by Type (2015-2020)
Table 48. APAC Human Vaccines Consumption by Application (2015-2020) (K Units)
Table 49. APAC Human Vaccines Consumption Market Share by Application (2015-2020)
Table 50. Europe Human Vaccines Consumption by Countries (2015-2020) (K Units)
Table 51. Europe Human Vaccines Consumption Market Share by Countries (2015-2020)
Table 52. Europe Human Vaccines Value by Countries (2015-2020) ($ Millions)
Table 53. Europe Human Vaccines Value Market Share by Countries (2015-2020)
Table 54. Europe Human Vaccines Consumption by Type (2015-2020) (K Units)
Table 55. Europe Human Vaccines Consumption Market Share by Type (2015-2020)
Table 56. Europe Human Vaccines Consumption by Application (2015-2020) (K Units)
Table 57. Europe Human Vaccines Consumption Market Share by Application (2015-2020)
Table 58. Middle East & Africa Human Vaccines Consumption by Countries (2015-2020) (K Units)
Table 59. Middle East & Africa Human Vaccines Consumption Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Human Vaccines Value by Countries (2015-2020) ($ Millions)
Table 61. Middle East & Africa Human Vaccines Value Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Human Vaccines Consumption by Type (2015-2020) (K Units)
Table 63. Middle East & Africa Human Vaccines Consumption Market Share by Type (2015-2020)
Table 64. Middle East & Africa Human Vaccines Consumption by Application (2015-2020) (K Units)
Table 65. Middle East & Africa Human Vaccines Consumption Market Share by Application (2015-2020)
Table 66. Human Vaccines Distributors List
Table 67. Human Vaccines Customer List
Table 68. Global Human Vaccines Consumption Forecast by Countries (2021-2025) (K Units)
Table 69. Global Human Vaccines Consumption Market Forecast by Regions
Table 70. Global Human Vaccines Value Forecast by Countries (2021-2025) ($ Millions)
Table 71. Global Human Vaccines Value Market Share Forecast by Regions
Table 72. Global Human Vaccines Consumption Forecast by Type (2021-2025) (K Units)
Table 73. Global Human Vaccines Consumption Market Share Forecast by Type (2021-2025)
Table 74. Global Human Vaccines Value Forecast by Type (2021-2025) ($ Millions)
Table 75. Global Human Vaccines Value Market Share Forecast by Type (2021-2025)
Table 76. Global Human Vaccines Consumption Forecast by Application (2021-2025) (K Units)
Table 77. Global Human Vaccines Consumption Market Share Forecast by Application (2021-2025)
Table 78. Global Human Vaccines Value Forecast by Application (2021-2025) ($ Millions)
Table 79. Global Human Vaccines Value Market Share Forecast by Application (2021-2025)
Table 80. CNBG Product Offered
Table 81. CNBG Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. CNBG Main Business
Table 83. CNBG Latest Developments
Table 84. CNBG Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. SANOFI Product Offered
Table 86. SANOFI Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. SANOFI Main Business
Table 88. SANOFI Latest Developments
Table 89. SANOFI Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. Changsheng Life Product Offered
Table 91. Changsheng Life Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. Changsheng Life Main Business
Table 93. Changsheng Life Latest Developments
Table 94. Changsheng Life Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. ChengDa Bio Product Offered
Table 96. ChengDa Bio Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. ChengDa Bio Main Business
Table 98. ChengDa Bio Latest Developments
Table 99. ChengDa Bio Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Kangtai Product Offered
Table 101. Kangtai Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. Kangtai Main Business
Table 103. Kangtai Latest Developments
Table 104. Kangtai Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Zhifei Product Offered
Table 106. Zhifei Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 107. Zhifei Main Business
Table 108. Zhifei Latest Developments
Table 109. Zhifei Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. Walvax Biotechnology Product Offered
Table 111. Walvax Biotechnology Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 112. Walvax Biotechnology Main Business
Table 113. Walvax Biotechnology Latest Developments
Table 114. Walvax Biotechnology Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 115. SINOVAC BIOTECH Product Offered
Table 116. SINOVAC BIOTECH Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. SINOVAC BIOTECH Main Business
Table 118. SINOVAC BIOTECH Latest Developments
Table 119. SINOVAC BIOTECH Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 120. GSK Product Offered
Table 121. GSK Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. GSK Main Business
Table 123. GSK Latest Developments
Table 124. GSK Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 125. Hissen Product Offered
Table 126. Hissen Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 127. Hissen Main Business
Table 128. Hissen Latest Developments
Table 129. Hissen Basic Information, Company Total Revenue (in $ million), Human Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 130. Adimmune Product Offered
Table 131. Adimmune Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 132. Adimmune Main Business
Table 133. Adimmune Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Adimmune Latest Developments
Table 135. Zhongyianke Biotech Product Offered
Table 136. Zhongyianke Biotech Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 137. Zhongyianke Biotech Main Business
Table 138. Zhongyianke Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Zhongyianke Biotech Latest Developments
Table 140. Rong An Product Offered
Table 141. Rong An Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 142. Rong An Main Business
Table 143. Rong An Latest Developments
Table 144. Rong An Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 145. Tiantan biological Product Offered
Table 146. Tiantan biological Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 147. Tiantan biological Main Business
Table 148. Tiantan biological Latest Developments
Table 149. Tiantan biological Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 150. Hualan Bio Product Offered
Table 151. Hualan Bio Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 152. Hualan Bio Main Business
Table 153. Hualan Bio Latest Developments
Table 154. Hualan Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 155. Changchun Baike Product Offered
Table 156. Changchun Baike Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 157. Changchun Baike Main Business
Table 158. Changchun Baike Latest Developments
Table 159. Changchun Baike Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 160. NuoCheng Bio Product Offered
Table 161. NuoCheng Bio Human Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 162. NuoCheng Bio Main Business
Table 163. NuoCheng Bio Latest Developments
Table 164. NuoCheng Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
LIST OF FIGURES
Figure 1. Picture of Human Vaccines
Figure 2. Human Vaccines Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Human Vaccines Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Human Vaccines Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Varicella
Figure 7. Product Picture of Influenza
Figure 8. Product Picture of Polio
Figure 9. Product Picture of Hepatitis A
Figure 10. Product Picture of Rabies
Figure 11. Product Picture of BCG
Figure 12. Product Picture of Hepatitis B
Figure 13. Product Picture of Other
Figure 14. Global Human Vaccines Consumption Market Share by Type (2015-2020)
Figure 15. Global Human Vaccines Value Market Share by Type (2015-2020)
Figure 16. Human Vaccines Consumed in Adults
Figure 17. Global Human Vaccines Market: Adults (2015-2020) (K Units)
Figure 18. Global Human Vaccines Market: Adults (2015-2020) ($ Millions)
Figure 19. Human Vaccines Consumed in Children
Figure 20. Global Human Vaccines Market: Children (2015-2020) (K Units)
Figure 21. Global Human Vaccines Market: Children (2015-2020) ($ Millions)
Figure 22. Global Human Vaccines Consumption Market Share by Application (2015-2020)
Figure 23. Global Human Vaccines Value Market Share by Application (2015-2020)
Figure 24. Global Human Vaccines Sales Market Share by Company in 2017
Figure 25. Global Human Vaccines Sales Market Share by Company in 2019
Figure 26. Global Human Vaccines Revenue Market Share by Company in 2017
Figure 27. Global Human Vaccines Revenue Market Share by Company in 2019
Figure 28. Global Human Vaccines Sale Price by Company in 2019
Figure 29. Global Human Vaccines Consumption Market Share by Regions 2015-2020
Figure 30. Global Human Vaccines Value Market Share by Regions 2015-2020
Figure 31. Americas Human Vaccines Consumption 2015-2020 (K Units)
Figure 32. Americas Human Vaccines Value 2015-2020 ($ Millions)
Figure 33. APAC Human Vaccines Consumption 2015-2020 (K Units)
Figure 34. APAC Human Vaccines Value 2015-2020 ($ Millions)
Figure 35. Europe Human Vaccines Consumption 2015-2020 (K Units)
Figure 36. Europe Human Vaccines Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Human Vaccines Consumption 2015-2020 (K Units)
Figure 38. Middle East & Africa Human Vaccines Value 2015-2020 ($ Millions)
Figure 39. Americas Human Vaccines Consumption Market Share by Countries in 2019
Figure 40. Americas Human Vaccines Value Market Share by Countries in 2019
Figure 41. Americas Human Vaccines Consumption Market Share by Type in 2019
Figure 42. Americas Human Vaccines Consumption Market Share by Application in 2019
Figure 43. United States Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 44. United States Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 46. Canada Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 47. Mexico Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 48. Mexico Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 49. APAC Human Vaccines Consumption Market Share by Countries in 2019
Figure 50. APAC Human Vaccines Value Market Share by Regions in 2019
Figure 51. APAC Human Vaccines Consumption Market Share by Type in 2019
Figure 52. APAC Human Vaccines Consumption Market Share by Application in 2019
Figure 53. China Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 54. China Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 55. Japan Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 56. Japan Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 57. Korea Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 58. Korea Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 59. Southeast Asia Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 60. Southeast Asia Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 61. India Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 62. India Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 63. Australia Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 64. Australia Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 65. Europe Human Vaccines Consumption Market Share by Countries in 2019
Figure 66. Europe Human Vaccines Value Market Share by Countries in 2019
Figure 67. Europe Human Vaccines Consumption Market Share by Type in 2019
Figure 68. Europe Human Vaccines Consumption Market Share by Application in 2019
Figure 69. Germany Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 70. Germany Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 71. France Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 72. France Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 73. UK Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 74. UK Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 75. Italy Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 76. Italy Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 77. Russia Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 78. Russia Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East & Africa Human Vaccines Consumption Market Share by Countries in 2019
Figure 80. Middle East & Africa Human Vaccines Value Market Share by Countries in 2019
Figure 81. Middle East & Africa Human Vaccines Consumption Market Share by Type in 2019
Figure 82. Middle East & Africa Human Vaccines Consumption Market Share by Application in 2019
Figure 83. Egypt Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 84. Egypt Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 85. South Africa Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 86. South Africa Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 87. Israel Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 88. Israel Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 89. Turkey Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 90. Turkey Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 91. GCC Countries Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 92. GCC Countries Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 93. Global Human Vaccines Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 94. Global Human Vaccines Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 95. Americas Human Vaccines Consumption 2021-2025 (K Units)
Figure 96. Americas Human Vaccines Value 2021-2025 ($ Millions)
Figure 97. APAC Human Vaccines Consumption 2021-2025 (K Units)
Figure 98. APAC Human Vaccines Value 2021-2025 ($ Millions)
Figure 99. Europe Human Vaccines Consumption 2021-2025 (K Units)
Figure 100. Europe Human Vaccines Value 2021-2025 ($ Millions)
Figure 101. Middle East & Africa Human Vaccines Consumption 2021-2025 (K Units)
Figure 102. Middle East & Africa Human Vaccines Value 2021-2025 ($ Millions)
Figure 103. United States Human Vaccines Consumption 2021-2025 (K Units)
Figure 104. United States Human Vaccines Value 2021-2025 ($ Millions)
Figure 105. Canada Human Vaccines Consumption 2021-2025 (K Units)
Figure 106. Canada Human Vaccines Value 2021-2025 ($ Millions)
Figure 107. Mexico Human Vaccines Consumption 2021-2025 (K Units)
Figure 108. Mexico Human Vaccines Value 2021-2025 ($ Millions)
Figure 109. Brazil Human Vaccines Consumption 2021-2025 (K Units)
Figure 110. Brazil Human Vaccines Value 2021-2025 ($ Millions)
Figure 111. China Human Vaccines Consumption 2021-2025 (K Units)
Figure 112. China Human Vaccines Value 2021-2025 ($ Millions)
Figure 113. Japan Human Vaccines Consumption 2021-2025 (K Units)
Figure 114. Japan Human Vaccines Value 2021-2025 ($ Millions)
Figure 115. Korea Human Vaccines Consumption 2021-2025 (K Units)
Figure 116. Korea Human Vaccines Value 2021-2025 ($ Millions)
Figure 117. Southeast Asia Human Vaccines Consumption 2021-2025 (K Units)
Figure 118. Southeast Asia Human Vaccines Value 2021-2025 ($ Millions)
Figure 119. India Human Vaccines Consumption 2021-2025 (K Units)
Figure 120. India Human Vaccines Value 2021-2025 ($ Millions)
Figure 121. Australia Human Vaccines Consumption 2021-2025 (K Units)
Figure 122. Australia Human Vaccines Value 2021-2025 ($ Millions)
Figure 123. Germany Human Vaccines Consumption 2021-2025 (K Units)
Figure 124. Germany Human Vaccines Value 2021-2025 ($ Millions)
Figure 125. France Human Vaccines Consumption 2021-2025 (K Units)
Figure 126. France Human Vaccines Value 2021-2025 ($ Millions)
Figure 127. UK Human Vaccines Consumption 2021-2025 (K Units)
Figure 128. UK Human Vaccines Value 2021-2025 ($ Millions)
Figure 129. Italy Human Vaccines Consumption 2021-2025 (K Units)
Figure 130. Italy Human Vaccines Value 2021-2025 ($ Millions)
Figure 131. Russia Human Vaccines Consumption 2021-2025 (K Units)
Figure 132. Russia Human Vaccines Value 2021-2025 ($ Millions)
Figure 133. Spain Human Vaccines Consumption 2021-2025 (K Units)
Figure 134. Spain Human Vaccines Value 2021-2025 ($ Millions)
Figure 135. Egypt Human Vaccines Consumption 2021-2025 (K Units)
Figure 136. Egypt Human Vaccines Value 2021-2025 ($ Millions)
Figure 137. South Africa Human Vaccines Consumption 2021-2025 (K Units)
Figure 138. South Africa Human Vaccines Value 2021-2025 ($ Millions)
Figure 139. Israel Human Vaccines Consumption 2021-2025 (K Units)
Figure 140. Israel Human Vaccines Value 2021-2025 ($ Millions)
Figure 141. Turkey Human Vaccines Consumption 2021-2025 (K Units)
Figure 142. Turkey Human Vaccines Value 2021-2025 ($ Millions)
Figure 143. GCC Countries Human Vaccines Consumption 2021-2025 (K Units)
Figure 144. GCC Countries Human Vaccines Value 2021-2025 ($ Millions)
Figure 145. CNBG Human Vaccines Market Share (2018-2020)
Figure 146. SANOFI Human Vaccines Market Share (2018-2020)
Figure 147. Changsheng Life Human Vaccines Market Share (2018-2020)
Figure 148. ChengDa Bio Human Vaccines Market Share (2018-2020)
Figure 149. Kangtai Human Vaccines Market Share (2018-2020)
Figure 150. Zhifei Human Vaccines Market Share (2018-2020)
Figure 151. Walvax Biotechnology Human Vaccines Market Share (2018-2020)
Figure 152. SINOVAC BIOTECH Human Vaccines Market Share (2018-2020)
Figure 153. GSK Human Vaccines Market Share (2018-2020)
Figure 154. Hissen Human Vaccines Market Share (2018-2020)
Figure 155. Adimmune Human Vaccines Market Share (2018-2020)
Figure 156. Zhongyianke Biotech Human Vaccines Market Share (2018-2020)
Figure 157. Rong An Human Vaccines Market Share (2018-2020)
Figure 158. Tiantan biological Human Vaccines Market Share (2018-2020)
Figure 159. Hualan Bio Human Vaccines Market Share (2018-2020)
Figure 160. Changchun Baike Human Vaccines Market Share (2018-2020)
Figure 161. NuoCheng Bio Human Vaccines Market Share (2018-2020)
Figure 1. Picture of Human Vaccines
Figure 2. Human Vaccines Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Human Vaccines Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Human Vaccines Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Varicella
Figure 7. Product Picture of Influenza
Figure 8. Product Picture of Polio
Figure 9. Product Picture of Hepatitis A
Figure 10. Product Picture of Rabies
Figure 11. Product Picture of BCG
Figure 12. Product Picture of Hepatitis B
Figure 13. Product Picture of Other
Figure 14. Global Human Vaccines Consumption Market Share by Type (2015-2020)
Figure 15. Global Human Vaccines Value Market Share by Type (2015-2020)
Figure 16. Human Vaccines Consumed in Adults
Figure 17. Global Human Vaccines Market: Adults (2015-2020) (K Units)
Figure 18. Global Human Vaccines Market: Adults (2015-2020) ($ Millions)
Figure 19. Human Vaccines Consumed in Children
Figure 20. Global Human Vaccines Market: Children (2015-2020) (K Units)
Figure 21. Global Human Vaccines Market: Children (2015-2020) ($ Millions)
Figure 22. Global Human Vaccines Consumption Market Share by Application (2015-2020)
Figure 23. Global Human Vaccines Value Market Share by Application (2015-2020)
Figure 24. Global Human Vaccines Sales Market Share by Company in 2017
Figure 25. Global Human Vaccines Sales Market Share by Company in 2019
Figure 26. Global Human Vaccines Revenue Market Share by Company in 2017
Figure 27. Global Human Vaccines Revenue Market Share by Company in 2019
Figure 28. Global Human Vaccines Sale Price by Company in 2019
Figure 29. Global Human Vaccines Consumption Market Share by Regions 2015-2020
Figure 30. Global Human Vaccines Value Market Share by Regions 2015-2020
Figure 31. Americas Human Vaccines Consumption 2015-2020 (K Units)
Figure 32. Americas Human Vaccines Value 2015-2020 ($ Millions)
Figure 33. APAC Human Vaccines Consumption 2015-2020 (K Units)
Figure 34. APAC Human Vaccines Value 2015-2020 ($ Millions)
Figure 35. Europe Human Vaccines Consumption 2015-2020 (K Units)
Figure 36. Europe Human Vaccines Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Human Vaccines Consumption 2015-2020 (K Units)
Figure 38. Middle East & Africa Human Vaccines Value 2015-2020 ($ Millions)
Figure 39. Americas Human Vaccines Consumption Market Share by Countries in 2019
Figure 40. Americas Human Vaccines Value Market Share by Countries in 2019
Figure 41. Americas Human Vaccines Consumption Market Share by Type in 2019
Figure 42. Americas Human Vaccines Consumption Market Share by Application in 2019
Figure 43. United States Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 44. United States Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 46. Canada Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 47. Mexico Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 48. Mexico Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 49. APAC Human Vaccines Consumption Market Share by Countries in 2019
Figure 50. APAC Human Vaccines Value Market Share by Regions in 2019
Figure 51. APAC Human Vaccines Consumption Market Share by Type in 2019
Figure 52. APAC Human Vaccines Consumption Market Share by Application in 2019
Figure 53. China Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 54. China Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 55. Japan Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 56. Japan Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 57. Korea Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 58. Korea Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 59. Southeast Asia Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 60. Southeast Asia Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 61. India Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 62. India Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 63. Australia Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 64. Australia Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 65. Europe Human Vaccines Consumption Market Share by Countries in 2019
Figure 66. Europe Human Vaccines Value Market Share by Countries in 2019
Figure 67. Europe Human Vaccines Consumption Market Share by Type in 2019
Figure 68. Europe Human Vaccines Consumption Market Share by Application in 2019
Figure 69. Germany Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 70. Germany Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 71. France Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 72. France Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 73. UK Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 74. UK Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 75. Italy Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 76. Italy Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 77. Russia Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 78. Russia Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East & Africa Human Vaccines Consumption Market Share by Countries in 2019
Figure 80. Middle East & Africa Human Vaccines Value Market Share by Countries in 2019
Figure 81. Middle East & Africa Human Vaccines Consumption Market Share by Type in 2019
Figure 82. Middle East & Africa Human Vaccines Consumption Market Share by Application in 2019
Figure 83. Egypt Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 84. Egypt Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 85. South Africa Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 86. South Africa Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 87. Israel Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 88. Israel Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 89. Turkey Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 90. Turkey Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 91. GCC Countries Human Vaccines Consumption Growth 2015-2020 (K Units)
Figure 92. GCC Countries Human Vaccines Value Growth 2015-2020 ($ Millions)
Figure 93. Global Human Vaccines Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 94. Global Human Vaccines Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 95. Americas Human Vaccines Consumption 2021-2025 (K Units)
Figure 96. Americas Human Vaccines Value 2021-2025 ($ Millions)
Figure 97. APAC Human Vaccines Consumption 2021-2025 (K Units)
Figure 98. APAC Human Vaccines Value 2021-2025 ($ Millions)
Figure 99. Europe Human Vaccines Consumption 2021-2025 (K Units)
Figure 100. Europe Human Vaccines Value 2021-2025 ($ Millions)
Figure 101. Middle East & Africa Human Vaccines Consumption 2021-2025 (K Units)
Figure 102. Middle East & Africa Human Vaccines Value 2021-2025 ($ Millions)
Figure 103. United States Human Vaccines Consumption 2021-2025 (K Units)
Figure 104. United States Human Vaccines Value 2021-2025 ($ Millions)
Figure 105. Canada Human Vaccines Consumption 2021-2025 (K Units)
Figure 106. Canada Human Vaccines Value 2021-2025 ($ Millions)
Figure 107. Mexico Human Vaccines Consumption 2021-2025 (K Units)
Figure 108. Mexico Human Vaccines Value 2021-2025 ($ Millions)
Figure 109. Brazil Human Vaccines Consumption 2021-2025 (K Units)
Figure 110. Brazil Human Vaccines Value 2021-2025 ($ Millions)
Figure 111. China Human Vaccines Consumption 2021-2025 (K Units)
Figure 112. China Human Vaccines Value 2021-2025 ($ Millions)
Figure 113. Japan Human Vaccines Consumption 2021-2025 (K Units)
Figure 114. Japan Human Vaccines Value 2021-2025 ($ Millions)
Figure 115. Korea Human Vaccines Consumption 2021-2025 (K Units)
Figure 116. Korea Human Vaccines Value 2021-2025 ($ Millions)
Figure 117. Southeast Asia Human Vaccines Consumption 2021-2025 (K Units)
Figure 118. Southeast Asia Human Vaccines Value 2021-2025 ($ Millions)
Figure 119. India Human Vaccines Consumption 2021-2025 (K Units)
Figure 120. India Human Vaccines Value 2021-2025 ($ Millions)
Figure 121. Australia Human Vaccines Consumption 2021-2025 (K Units)
Figure 122. Australia Human Vaccines Value 2021-2025 ($ Millions)
Figure 123. Germany Human Vaccines Consumption 2021-2025 (K Units)
Figure 124. Germany Human Vaccines Value 2021-2025 ($ Millions)
Figure 125. France Human Vaccines Consumption 2021-2025 (K Units)
Figure 126. France Human Vaccines Value 2021-2025 ($ Millions)
Figure 127. UK Human Vaccines Consumption 2021-2025 (K Units)
Figure 128. UK Human Vaccines Value 2021-2025 ($ Millions)
Figure 129. Italy Human Vaccines Consumption 2021-2025 (K Units)
Figure 130. Italy Human Vaccines Value 2021-2025 ($ Millions)
Figure 131. Russia Human Vaccines Consumption 2021-2025 (K Units)
Figure 132. Russia Human Vaccines Value 2021-2025 ($ Millions)
Figure 133. Spain Human Vaccines Consumption 2021-2025 (K Units)
Figure 134. Spain Human Vaccines Value 2021-2025 ($ Millions)
Figure 135. Egypt Human Vaccines Consumption 2021-2025 (K Units)
Figure 136. Egypt Human Vaccines Value 2021-2025 ($ Millions)
Figure 137. South Africa Human Vaccines Consumption 2021-2025 (K Units)
Figure 138. South Africa Human Vaccines Value 2021-2025 ($ Millions)
Figure 139. Israel Human Vaccines Consumption 2021-2025 (K Units)
Figure 140. Israel Human Vaccines Value 2021-2025 ($ Millions)
Figure 141. Turkey Human Vaccines Consumption 2021-2025 (K Units)
Figure 142. Turkey Human Vaccines Value 2021-2025 ($ Millions)
Figure 143. GCC Countries Human Vaccines Consumption 2021-2025 (K Units)
Figure 144. GCC Countries Human Vaccines Value 2021-2025 ($ Millions)
Figure 145. CNBG Human Vaccines Market Share (2018-2020)
Figure 146. SANOFI Human Vaccines Market Share (2018-2020)
Figure 147. Changsheng Life Human Vaccines Market Share (2018-2020)
Figure 148. ChengDa Bio Human Vaccines Market Share (2018-2020)
Figure 149. Kangtai Human Vaccines Market Share (2018-2020)
Figure 150. Zhifei Human Vaccines Market Share (2018-2020)
Figure 151. Walvax Biotechnology Human Vaccines Market Share (2018-2020)
Figure 152. SINOVAC BIOTECH Human Vaccines Market Share (2018-2020)
Figure 153. GSK Human Vaccines Market Share (2018-2020)
Figure 154. Hissen Human Vaccines Market Share (2018-2020)
Figure 155. Adimmune Human Vaccines Market Share (2018-2020)
Figure 156. Zhongyianke Biotech Human Vaccines Market Share (2018-2020)
Figure 157. Rong An Human Vaccines Market Share (2018-2020)
Figure 158. Tiantan biological Human Vaccines Market Share (2018-2020)
Figure 159. Hualan Bio Human Vaccines Market Share (2018-2020)
Figure 160. Changchun Baike Human Vaccines Market Share (2018-2020)
Figure 161. NuoCheng Bio Human Vaccines Market Share (2018-2020)
